A Patent-Pending Live Plant Transporter to Target
Home Grow Market
TSX: ACB
VANCOUVER, Oct. 5, 2017
/CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB)
(OTCQX: ACBFF) (Frankfurt: 21P;
WKN: A1C4WM) today is pleased to announce that the Company will be
launching its proprietary and patent-pending live plant
transporter, the Aurora Envoy™ ("Envoy"). The
Company filed its patent application on August 31, 2017, providing Aurora with the
opportunity to pursue patent protection in over 150 countries.
The Aurora Envoy™ possesses several novel and
inventive features that promote the health, vigor and vegetative
growth of live plant cuttings during shipment, leading to high
transplant success rates and an exceptional customer
experience.
Neil Belot, Chief Global Business
Development Officer for Aurora, added, "Our team looked at all
available options on the market. We were unable to find one
that met the Aurora Standard, and consequently we developed our
own. Following months of thorough testing and design
iterations, we are proud to say that no other comparable product on
the market today offers the same level of technological
sophistication as the Aurora Envoy™. We employ one of
the best and brightest industrial designers in this industry, and
with the support of our exceptional team, we have once again set a
new standard for the cannabis industry."
The Aurora Envoy™, which is anticipated to launch
commercially in the coming months, incorporates several key
innovative features including:
- Child-proof and tamper evident design;
- Long-lasting internal power source (+200 hours);
- Four powerful light emitting diodes optimized for vegetative
plant growth;
- Opaque textured white-matte interior finish for increased
reflection and even light distribution;
- Breathable container design for effective air exchange and
improved plant health, and
- Wide-mouth design to eliminate potential condensation
issues.
"The Envoy brings together our guiding principle of
patients-first with our ongoing support of peoples' ability to make
the choice to grow at home," said Terry
Booth, CEO. "The Envoy is therefore the perfect complement
to our home garden offering through BC Northern Lights, which we
recently acquired. Enabling people to grow at home, to achieve
higher success rates and produce exceptional yields while
effectively addressing all of the issues previously raised by the
public and municipal governments, is a huge step forward in helping
to build this important segment of the cannabis industry."
Aurora intends to wholesale the Envoy on a worldwide basis, and
has designed the manufacturing process in a way that enables
cannabis producers and other plant producers to customize the Envoy
with their own branding.
About Aurora
Aurora's wholly-owned subsidiary, Aurora Cannabis Enterprises
Inc., is a licensed producer of medical cannabis pursuant to Health
Canada's Access to Cannabis for Medical Purposes Regulations
("ACMPR"). The Company operates a 55,200 square foot,
state-of-the-art production facility in Mountain View County,
Alberta, known as "Aurora
Mountain", is currently constructing a second 800,000 square foot
production facility, known as "Aurora Sky", at the Edmonton International Airport, and has
acquired, and is undertaking completion of a third 40,000 square
foot production facility in Pointe-Claire, Quebec, on Montreal's West Island.
In addition, the Company holds approximately 9.6% of the issued
shares (12.9% on a fully-diluted basis) in leading extraction
technology company Radient Technologies Inc., based in Edmonton, and is in the process of completing
an investment in Edmonton-based
Hempco Food and Fiber for an ownership stake of up to 50.1%.
Furthermore, Aurora is the cornerstone investor with a 19.9% stake
in Cann Group Limited, the first Australian company licensed to
conduct research on and cultivate medical cannabis. Aurora also
owns Pedanios, a leading wholesale importer, exporter, and
distributor of medical cannabis in the European Union, based in
Germany. The Company offer further
differentiation through the acquisition of BC Northern Lights Ltd.
And Urban Cultivator Inc., industry leaders in the production and
sale of proprietary systems for the safe, efficient and high-yield
indoor cultivation of cannabis, and in state-of-the-art indoor
gardening appliances for the cultivation of organic microgreens,
vegetables and herbs in home kitchens. Aurora's common shares
trade on TSX under the symbol "ACB".
On behalf of the Board of Directors,
AURORA CANNABIS INC.
Terry Booth
CEO
This news release includes statements containing certain
"forward-looking information" within the meaning of applicable
securities law ("forward-looking statements"). Forward-looking
statements are frequently characterized by words such as "plan",
"continue", "expect", "project", "intend", "believe", "anticipate",
"estimate", "may", "will", "potential", "proposed" and other
similar words, or statements that certain events or conditions
"may" or "will" occur. These statements are only predictions.
Various assumptions were used in drawing the conclusions or making
the projections contained in the forward-looking statements
throughout this news release. Forward-looking statements are based
on the opinions and estimates of management at the date the
statements are made, and are subject to a variety of risks and
uncertainties and other factors that could cause actual events or
results to differ materially from those projected in the
forward-looking statements. The Company is under no obligation, and
expressly disclaims any intention or obligation, to update or
revise any forward-looking statements, whether as a result of new
information, future events or otherwise, except as expressly
required by applicable law.
Neither TSX nor its Regulation Services Provider (as that
term is defined in the policies of Toronto Stock Exchange) accepts
responsibility for the adequacy or accuracy of this
release.
SOURCE Aurora Cannabis Inc.